A detailed history of Y Intercept (Hong Kong) LTD transactions in Axogen, Inc. stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 14,285 shares of AXGN stock, worth $256,558. This represents 0.02% of its overall portfolio holdings.

Number of Shares
14,285
Holding current value
$256,558
% of portfolio
0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 04, 2025

BUY
$12.47 - $17.19 $178,133 - $245,559
14,285 New
14,285 $235,000
Q1 2024

May 10, 2024

SELL
$6.63 - $10.69 $10,356 - $16,697
-1,562 Reduced 6.22%
23,562 $190,000
Q4 2023

Feb 13, 2024

BUY
$3.61 - $7.76 $8,887 - $19,105
2,462 Added 10.86%
25,124 $171,000
Q3 2023

Nov 14, 2023

BUY
$4.68 - $9.26 $106,058 - $209,850
22,662 New
22,662 $113,000

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $759M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Y Intercept (Hong Kong) LTD Portfolio

Follow Y Intercept (Hong Kong) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.